SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0001104659-20-132899
Filing Date
2020-12-07
Accepted
2020-12-07 16:45:25
Documents
9

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1366656
2 filename2.htm EX-3.1 261085
3 filename3.htm EX-10.2 22198
4 filename4.htm EX-10.5 53926
5 GRAPHIC tm2037689d1_ex3-1img001.jpg GRAPHIC 7946
6 GRAPHIC tm2037689d1_ex3-1s1img001.jpg GRAPHIC 11954
7 GRAPHIC tm2037689d1_ex3-1s1img002.jpg GRAPHIC 16553
8 GRAPHIC tm2037689d1_ex3-1s2img001.jpg GRAPHIC 12218
9 GRAPHIC tm2037689d1_ex3-1sp3img001.jpg GRAPHIC 11832
  Complete submission text file 0001104659-20-132899.txt   1789037
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Filer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-03858 | Film No.: 201373203
SIC: 6770 Blank Checks